JP2015520196A5 - - Google Patents

Download PDF

Info

Publication number
JP2015520196A5
JP2015520196A5 JP2015516276A JP2015516276A JP2015520196A5 JP 2015520196 A5 JP2015520196 A5 JP 2015520196A5 JP 2015516276 A JP2015516276 A JP 2015516276A JP 2015516276 A JP2015516276 A JP 2015516276A JP 2015520196 A5 JP2015520196 A5 JP 2015520196A5
Authority
JP
Japan
Prior art keywords
dengue virus
immunogenic composition
administration
immunogenic
serotypes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015516276A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015520196A (ja
Filing date
Publication date
Priority claimed from US13/492,884 external-priority patent/US8968996B2/en
Application filed filed Critical
Priority claimed from PCT/US2013/045041 external-priority patent/WO2013188315A1/en
Publication of JP2015520196A publication Critical patent/JP2015520196A/ja
Publication of JP2015520196A5 publication Critical patent/JP2015520196A5/ja
Pending legal-status Critical Current

Links

JP2015516276A 2012-06-10 2013-06-10 デングウイルスに対するワクチン投与のための組成物および方法 Pending JP2015520196A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/492,884 2012-06-10
US13/492,884 US8968996B2 (en) 2009-06-01 2012-06-10 Compositions and methods for rapid immunization against dengue virus
PCT/US2013/045041 WO2013188315A1 (en) 2012-06-10 2013-06-10 Compositions and methods for administration of vaccines against dengue virus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018030539A Division JP2018090618A (ja) 2012-06-10 2018-02-23 デングウイルスに対する免疫原性組成物およびワクチンキット

Publications (2)

Publication Number Publication Date
JP2015520196A JP2015520196A (ja) 2015-07-16
JP2015520196A5 true JP2015520196A5 (OSRAM) 2016-07-28

Family

ID=48652375

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015516276A Pending JP2015520196A (ja) 2012-06-10 2013-06-10 デングウイルスに対するワクチン投与のための組成物および方法
JP2018030539A Withdrawn JP2018090618A (ja) 2012-06-10 2018-02-23 デングウイルスに対する免疫原性組成物およびワクチンキット

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018030539A Withdrawn JP2018090618A (ja) 2012-06-10 2018-02-23 デングウイルスに対する免疫原性組成物およびワクチンキット

Country Status (6)

Country Link
EP (1) EP2858668A1 (OSRAM)
JP (2) JP2015520196A (OSRAM)
CA (1) CA2915027A1 (OSRAM)
NZ (1) NZ630831A (OSRAM)
TW (1) TW201402143A (OSRAM)
WO (1) WO2013188315A1 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2933472A1 (en) * 2012-12-14 2014-06-19 Takeda Vaccines, Inc. Compositions, methods of administration and uses for trivalent dengue virus formulations
ES2933970T3 (es) 2013-03-15 2023-02-15 Takeda Vaccines Inc Composiciones y métodos para construcciones quiméricas de virus del dengue en vacunas
JP2018522880A (ja) 2015-07-02 2018-08-16 プライムヴァックス イミュノ−オンコロジー,インク. デングウイルス及び樹状細胞による併用療法のための組成物及び方法
CA2999881A1 (en) 2015-09-26 2017-03-30 PrimeVax Immuno-Oncology, Inc. Compositions and methods for producing dendritic cells
CA3020484A1 (en) * 2016-04-13 2017-10-19 Takeda Vaccines, Inc. Compositions and methods of vaccination against dengue virus in children and young adults
TWI625393B (zh) * 2016-11-15 2018-06-01 國立清華大學 對抗複數種登革熱病毒血清型之疫苗套組及其製備方法與用途
CN110139671A (zh) 2016-11-16 2019-08-16 普莱瓦克斯免疫肿瘤学公司 用于治疗癌症的组合免疫疗法
WO2018129202A1 (en) 2017-01-04 2018-07-12 PrimeVax Immuno-Oncology, Inc. Compositions and methods for therapy with dengue virus
US11426461B2 (en) 2018-09-05 2022-08-30 Takeda Vaccines, Inc. Methods for preventing dengue and hepatitis A
US11464815B2 (en) 2018-09-05 2022-10-11 Takeda Vaccines, Inc. Dengue vaccine unit dose and administration thereof
CA3111332A1 (en) 2018-09-05 2020-03-12 Takeda Vaccines, Inc. Dengue vaccine unit dose and administration thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8110196B2 (en) * 2005-04-29 2012-02-07 Polytopas LLC Methods and compositions for polytopic vaccination
FR2906724B1 (fr) * 2006-10-04 2009-03-20 Sanofi Pasteur Sa Methode d'immunisation contre les 4 serotypes de la dengue.
NZ618158A (en) * 2009-06-01 2015-05-29 Takeda Vaccines Inc Compositions and methods for administration of vaccines against dengue virus
US8968996B2 (en) * 2009-06-01 2015-03-03 Takeda Vaccines, Inc. Compositions and methods for rapid immunization against dengue virus

Similar Documents

Publication Publication Date Title
JP2015520196A5 (OSRAM)
Levin et al. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same?
ES2731899T3 (es) Composición de vacuna nasal contra la gripe
MX2021001762A (es) Metodo y composicion para estimular la respuesta inmunitaria.
AR096203A1 (es) Dosificaciones y métodos para administrar moléculas de ácido nucleico formuladas en lípidos
JP2012528794A5 (OSRAM)
JP2011525911A5 (OSRAM)
NZ606993A (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
JP2017533972A5 (OSRAM)
JP2018505882A5 (OSRAM)
NZ597000A (en) Compositions and methods for administration of vaccines against dengue virus
NZ630831A (en) Compositions and methods for administration of vaccines against dengue virus
Shakya et al. Microneedle-mediated allergen-specific immunotherapy for the treatment of airway allergy in mice
MX364800B (es) Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca.
JP2016531895A5 (OSRAM)
PH12013501373B1 (en) Bovine viral diarrhea virus type 1b vaccine compositions and methods
JP2012001565A5 (OSRAM)
Shin et al. Effect of zymosan and poly (I: C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine
HRP20200142T1 (hr) Postupci i sastavi za liječenje depresije uporabom ciklobenzaprina
Kimoto et al. Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice
EA201592040A1 (ru) Иммуногенная композиция для применения в терапии
JP2016521754A5 (OSRAM)
JP2016531853A5 (OSRAM)
JP2017511327A5 (OSRAM)
JP2016534062A5 (OSRAM)